Amy Demicco

Amy DeMicco is a highly experienced professional in the field of translational medicine and pharmacology, currently serving as the Associate Director of Translational Medicine at Exelixis since September 2021. In this role, Amy manages preclinical biology experiments to support early clinical-phase drug candidates and provides essential preclinical data for decision-making regarding clinical indications and therapeutic strategies. Prior to this, Amy worked at AstraZeneca from November 2015 to September 2021 as an Associate Principal Scientist, leading in vitro biology activities for respiratory disease projects. Academic credentials include a Ph.D. in Cell and Molecular Biology from the University of Pennsylvania, where independent research focused on the cell cycle regulation in lymphocytes, and a Bachelor of Science in Biochemistry from Rutgers University.